The genetic-testing industry has come under the microscope again after Myriad Genetics, Inc. (NASDAQ:MYGN) breast-cancer gene test got a big reimbursement cut from the federal government, adding pressure to a field whose 2014 outlook is cloudy. Myriad Genetics, Inc. (NASDAQ:MYGN) stock opened at $21.81 in last session, and closed at $21.20, while the day range of MYGN stock is $21.16 – $21.96. The stock showed a negative weekly performance of -12.36%.
The Retail-Restaurants industry group has risen steadily this year, thanks in part to Spotlight stocks Ruth’s Hospitality Group, Inc. (NASDAQ:RUTH). The group is up nearly 50% in 2013, easily outpacing the S&P 500. Ruth’s Hospitality Group, Inc. (NASDAQ:RUTH) stock opened at $13.52, in last session and closed at $13.62, by gaining 0.74%. The 52 week range of the stock is $7.27 – $15.30. Company’s market capitalization is $484.89 billion.
Lionbridge Technologies (NASDAQ:LIOX) was upgraded by investment analysts at Jefferson Research from a “hold” rating to a “buy” rating in a note issued to investors on Friday, AmericanBankingNews.com reports. Lionbridge Technologies, Inc. (NASDAQ:LIOX) stock advanced 0.87% and finished the last session at $5.80. The EPS of the stock remained 0.14. Company’s market capitalization is $369.17billion.